← Leaderboards
Kehmia Nubonyin Titanji
Emory University
$746,526
Attributed
$746,526
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $196.3K · FY2016–21$200K$150K$100K$50K$0
'16
'17
'18
'19
'20
'21
Funding mix
By agency
NIH$746,526 · 2
By mechanism
K01$590,526 · 1
R03$156,000 · 1
Top collaborators
No co-investigators on record.
Most similar at Emory University
Same institution · by research overlap
- Ighovwerha Ofotokun$45,259,838
- Roberto Pacifici$20,489,635
- John P Bilezikian$25,660,421
- George R Beck$2,971,982
- Manoj Thapa$618,461
Others in their field
Top investigators on “Novel Strategies”
- Judith S. Currier · University Of California Los Angeles$321,300,358
- Gerald T Nepom · Benaroya Research Inst At Virginia Mason$305,871,236
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$303,952,589
- Richard A Gibbs · Baylor College Of Medicine$295,698,028
- Constance Ann Benson · University Of California, San Diego$278,253,569
- Dennis R. Burton · Scripps Research Institute$256,423,824
Research focus
Novel StrategiesMorbidity - Disease RateInfectionMortalityInfluenzaMemory B-LymphocyteCytokineFunctional DisorderImpairmentImmune ResponseCell PhysiologyAntibody ResponseAgingAntigensAids/Hiv ProblemBisphosphonateBone ResorptionB-LymphocytesFundingAntiretroviral TherapyAntibodiesHiv InfectionsAntibody FormationPharmaceutical Preparations
Grant awards (7)
Enhancing B cell maturation and function using bisphosphonates in HIV$78,000
R03 · FY2021 · HL · contact PI
Reversing HIV-induced B cell dysfunction with bisphosphonates$118,272
K01 · FY2020 · HL · contact PI
Enhancing B cell maturation and function using bisphosphonates in HIV$78,000
R03 · FY2020 · HL · contact PI
Reversing HIV-induced B cell dysfunction with bisphosphonates$122,664
K01 · FY2019 · HL · contact PI
Reversing HIV-induced B cell dysfunction with bisphosphonates$121,124
K01 · FY2018 · HL · contact PI
Reversing HIV-induced B cell dysfunction with bisphosphonates$115,895
K01 · FY2017 · HL · contact PI
Reversing HIV-induced B cell dysfunction with bisphosphonates$112,571
K01 · FY2016 · HL · contact PI